NCT04971135View on ClinicalTrials.gov

First-in-human Study of SAN711 in Healthy Participants

PHASE1UnknownINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions

Healthy

Interventions

DRUG

SAN711

SAN711 liquid formulation

OTHER

Placebo

Matching placebo

Trial Locations (1)

NW10 7EW

RECRUITING

Hammersmith Medicines Research (HMR), London

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Medpace, Inc.

INDUSTRY

lead

Saniona

INDUSTRY